Pakistan Science Abstracts
Article details & metrics
No Detail Found!!
Tirofiban and Rivaroxaban use in the management of right coronary artery thrombus as a primary manifestation of essential thrombocythemia
Author(s):
1. Muhummad Nasir Rahman: Department of Cardiology, Aga Khan University Hospital,Karachi,Pakistan
2. Maleeha Javed: Department of Cardiology, Aga Khan University Hospital,Karachi,Pakistan
Abstract:
A 45 year old male with hypertension was presented to our centre with a recent inferior wall myocardial infarction (IWMI) and post infarction angina. Invasive coronary angiography revealed an occluded proximal right coronary artery (RCA) with high thrombus burden, in the absence of obstructive disease in the remaining coronary vasculature. Based on raised platelet counts of 923,000/microliter and positive Janus kinase (JAK 2- V617) mutations tested by polymerase chain reaction (PCR), a diagnosis of essential thrombocythemia (ET) was made. A therapeutic strategy of aspiration thrombectomy along with I/V Tirofi ban was used for three days, followed by reassessed angiogram and percutaneous coronary intervention (PCI) with drug eluting stent (DES) placement was applied. In addition to dual antiplatelet and statin therapy, patient was treated with Rivaroxaban 15 mg once daily for a month and Hydroxyurea 500mg twice daily. At one month follow up, patient was asymptomatic, with decreasing platelet counts and no bleeding complications.
Page(s): 557-559
DOI: DOI not available
Published: Journal: Journal of Pakistan Medical Association, Volume: 72, Issue: 3, Year: 2022
Keywords:
Inferior wall MI High thrombus burden Essential thrombocythemia Tirofi ban Rivaroxaban
References:
References are not available for this document.
Citations
Citations are not available for this document.
0

Citations

0

Downloads

23

Views